Biliary Tract Neoplasms
69
6
12
25
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
11 trials with published results (16%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
7.2%
5 terminated out of 69 trials
83.3%
-3.2% vs benchmark
12%
8 trials in Phase 3/4
44%
11 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (69)
EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)
EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)
Impact of Intraoperative PTCD Catheter Retention Versus Removal on Postoperative Short-term Outcomes After Pancreaticoduodenectomy in Obstructive Jaundice
Agnostic Therapy in Rare Solid Tumors
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer
Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers
Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)
Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers
Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer
Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope
The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic Cancer
The Safety and Efficacy of Benmelstobart Injection in Patients With Advanced Biliary Tract Malignant Tumors
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC
A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy